Posted by  keeptalkinggreece in Very Mix
         
CHICAGO (MarketWatch) — The Securities and Exchange Commission on 
Monday charged medical device company Smith & Nephew under the 
Foreign Corrupt Practices Act for bribing Greek public doctors over more
 than a decade. Smith & Nephew will pay more than $22 million as 
part of a deal with the SEC and U.S. Department of Justice. The 
complaint alleges that Smith & Nephew subsidiaries used a 
distributor that created a “slush fund” to forward payments to doctors 
working at government hospitals in Greece in order to win business. 
“Smith & Nephew’s subsidiaries chose a path of corruption rather 
than fair and honest competition,” said Kara Brockmeyer, chief of the 
SEC enforcement division’s Foreign Corrupt Practices Act unit. “The SEC 
will continue to hold companies liable as we investigate the medical 
device industry for this type of illegal behavior.”
No comments:
Post a Comment